Home/Filings/4/0001104659-22-005451
4//SEC Filing

Wiley Matthew T. 4

Accession 0001104659-22-005451

CIK 0001720893other

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 4:19 PM ET

Size

5.5 KB

Accession

0001104659-22-005451

Insider Transaction Report

Form 4
Period: 2022-01-17
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-01-17+85,00085,000 total
    Exercise: $19.50Exp: 2032-01-16Common Stock (85,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of January 17, 2022 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Issuer

BioXcel Therapeutics, Inc.

CIK 0001720893

Entity typeother

Related Parties

1
  • filerCIK 0001759703

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 4:19 PM ET
Size
5.5 KB